Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
-
Published:2020-12-09
Issue:5
Volume:124
Page:1026-1032
-
ISSN:0007-0920
-
Container-title:British Journal of Cancer
-
language:en
-
Short-container-title:Br J Cancer
Author:
Andersson Therese M.-L.ORCID, Rutherford Mark J.ORCID, Myklebust Tor Åge, Møller Bjørn, Soerjomataram Isabelle, Arnold Melina, Bray Freddie, Parkin D. Max, Sasieni PeterORCID, Bucher Oliver, De Prithwish, Engholm Gerda, Gavin Anna, Little Alana, Porter Geoff, Ramanakumar Agnihotram V., Saint-Jacques Nathalie, Walsh Paul M., Woods Ryan R., Lambert Paul C.
Abstract
Abstract
Background
Data from population-based cancer registries are often used to compare cancer survival between countries or regions. The ICBP SURVMARK-2 study is an international partnership aiming to quantify and explore the reasons behind survival differences across high-income countries. However, the magnitude and relevance of differences in cancer survival between countries have been questioned, as it is argued that observed survival variations may be explained, at least in part, by differences in cancer registration practice, completeness and the availability and quality of the respective data sources.
Methods
As part of the ICBP SURVMARK-2 study, we used a simulation approach to better understand how differences in completeness, the characteristics of those missed and inclusion of cases found from death certificates can impact on cancer survival estimates.
Results
Bias in 1- and 5-year net survival estimates for 216 simulated scenarios is presented. Out of the investigated factors, the proportion of cases not registered through sources other than death certificates, had the largest impact on survival estimates.
Conclusion
Our results show that the differences in registration practice between participating countries could in our most extreme scenarios explain only a part of the largest observed differences in cancer survival.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference20 articles.
1. Parkin, D. M. The evolution of the population-based cancer registry. Nat. Rev. Cancer 6, 603–612 (2006). 2. Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X. S. et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385, 977–1010 (2015). 3. De Angelis, R., Sant, M., Coleman, M. P., Francisci, S., Baili, P., Pierannunzio, D. et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol. 15, 23–34 (2014). 4. Coleman, M. P., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C. et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377, 127–138 (2011). 5. Does the UK really have an effective cancer plan? Lancet Oncol. 8, 747 (2007).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|